Head and Neck Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Head and Neck
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA3132 |
|---|---|
| Cancer Type: | Head and Neck |
| Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
| Protocol | RTOG 1216 |
|---|---|
| Cancer Type: | Pathologic High-Risk Squamous Cell Cancer |
| Fast Facts |
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG HN010 |
|---|---|
| Cancer Type: | RARE |
A CONTROLLED, RANDOMIZED PHASE II TRIAL OF DOCETAXEL PLUS TRASTUZUMAB VERSUS ADO-TRASTUZUMAB EMTANSINE FOR RECURRENT, METASTATIC, OR TREATMENT-NAÏVE, UNRESECTABLE HER2-POSITIVE SALIVARY GLAND CANCER
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
